Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein
  2. Tsuji, Kohei; Tamamura, Hirokazu; Burke,Terrence
  3. Bioorganic & Medicinal Chemistry . 2024, Dec 28; 119: 118055.
  1. 2.   Structural and biochemical properties of L-asparaginase
  2. Lubkowski,Jacek; Wlodawer,Alexander
  3. The FEBS journal. 2021, Jun 19;
  1. 3.   Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1.
  2. Hymel, David; Burke, Terrence R
  3. ChemMedChem. 2017, Feb 3; 12(3): 202-206.
  1. 4.   CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
  2. Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Connelly, J. W.; Monks, A.; Shoemaker, R. H.; Abaan, O. D.; Davis, S. R.; Meltzer, P. S.; Doroshow, J. H.; Pommier, Y.
  3. Oncogene. 2012, Jan; 31(4): 403-418.
  1. 5.   Optimization of a Cyclic Peptide Inhibitor of Ser/Thr Phosphatase PPM1D (Wip1)
  2. Hayashi, R.; Tanoue, K.; Durell, S. R.; Chatterjee, D. K.; Jenkins, L. M. M.; Appella, D. H.; Appella, E.
  3. Biochemistry. 2011, May; 50(21): 4537-4549.
  1. 6.   Polo-box domain: a versatile mediator of polo-like kinase function
  2. Park, J. E.; Soung, N. K.; Johmura, Y.; Kang, Y. H.; Liao, C.; Lee, K. H.; Park, C. H.; Nicklaus, M. C.; Lee, K. S.
  3. Cellular and Molecular Life Sciences. 2010, Jun; 67(12): 1957-1970.
  1. 7.   KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals
  2. Dougherty, M. K.; Ritt, D. A.; Zhou, M.; Specht, S. I.; Monson, D. M.; Veenstra, T. D.; Morrison, D. K.
  3. Molecular Cell. 2009, Jun 26; 34(6): 652-62.
  1. 8.   Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]
  2. Jobson, A. G.; Lountos, G. T.; Lorenzi, P. L.; Llamas, J.; Connelly, J.; Cerna, D.; Tropea, J. E.; Onda, A.; Zoppoli, G.; Kondapaka, S.; Zhang, G. T.; Caplen, N. J.; Cardellina, J. H.; Yoo, S. S.; Monks, A.; Self, C.; Waugh, D. S.; Shoemaker, R. H.
  3. Journal of Pharmacology and Experimental Therapeutics. 2009 331(3): 816-826.
  1. 9.   TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans
  2. Washington, A. V.; Gibot, S.; Acevedo, I.; Gattis, J.; Quigley, L.; Feltz, R.; De La Mota, A.; Schubert, R. L.; Gomez-Rodriguez, J.; Cheng, J.; Dutra, A.; Pak, E.; Chertov, O.; Rivera, L.; Morales, J.; Lubkowski, J.; Hunter, R.; Schwartzberg, P. L.
  3. Journal of Clinical Investigation. 2009 119(6): 1489-1501.
  1. 10.   Structure-activity relationship studies for the peptide portion of the bladder epithelial cell antiproliferative factor from interstitial cystitis patients
  2. Kaczmarek, P.; Keay, S. K.; Tocci, G. M.; Koch, K. R.; Zhang, C. O.; Barchi, J. J.; Grkovic, D.; Guo, L.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2008 51(19): 5974-5983.
  1. 11.   Identification of a bis-guanylhydrazone 4,4 '-diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555 as a novel chemotype for inhibition of Chk2 kinase
  2. Jobson, A. G.; Cardellina, J. H.; Scudiero, D.; Kondapaka, S.; Zhang, H.; Kim, H.; Shoemaker, R.; Pommier, Y.
  3. Molecular Pharmacology. 2007, Oct; 72(4): 876-884.
  1. 12.   Nitric oxide regulates prolidase activity by serine/threonine phosphorylation
  2. Surazynski, A.; Liu, Y. M.; Miltyk, W.; Phang, J. M.
  3. Journal of Cellular Biochemistry. 2005, DEC 1; 96(5): 1086-1094.
  1. 13.   Substrate specificity of the human protein phosphatase 2C delta Wip1
  2. Yamaguchi, H.; Minopoli, G.; Demidov, O. N.; Chatterjee, D. K.; Anderson, C. W.; Durell, S. R.; Appella, E.
  3. Biochemistry. 2005, APR 12; 44(14): 5285-5294.
  1. 14.   The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity
  2. Kaldis, P.
  3. Journal of Biological Chemistry. 2005, MAR 25; 280(12): 11165-11174.
  1. 15.   Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes
  2. Nijhara, R.; van Hennik, P. B.; Gignac, M. L.; Kruhlak, M. J.; Hordijk, P. L.; Delon, J.; Shaw, S.
  3. Journal of Immunology. 2004, OCT 15; 173(8): 4985-4993.
  1. 16.   Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis
  2. Julias, J. G.; Boyer, P. L.; McWilliams, M. J.; Alvord, W. G.; Hughes, S. H.
  3. Virology. 2004 322(1): 13-21.
  1. 17.   Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization
  2. Brown, M. J.; Nijhara, R.; Hallam, J. A.; Gignac, M.; Yamada, K. M.; Erlandsen, S. L.; Delon, J.; Kruhlak, M.; Shaw, S.
  3. Blood. 2003 102(12): 3890-3899.
  1. 18.   Update on D-Ala-Peptide T-Amide (DAPTA): A viral entry inhibitor that blocks CCR5 chemokine receptors
  2. Ruff, M. R.; Polianova, M.; Yang, Q. E.; Leoung, G. S.; Ruscetti, F. W.; Pert, C. B.
  3. Current HIV Research. 2003 1(1): 51-67.
  1. 19.   Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
  2. Duesbery, N. S.; Resau, J.; Webb, C. P.; Koochekpour, S.; Koo, H. M.; Leppla, S. H.; Woude, G. F. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(7): 4089-4094.
  1. 20.   Characterization of the mouse JAB1 cDNA and protein
  2. Bounpheng, M. A.; Melnikova, I. N.; Dodds, S. G.; Chen, H. P.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Christy, B. A.
  3. Gene. 2000 242(1-2): 41-50.
  1. 21.   Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity
  2. Kawai, T.; Nomura, F.; Hoshino, K.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Akira, S.
  3. Oncogene. 1999 18(23): 3471-3480.
  1. 22.   Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex
  2. Feng, Y.; Hodge, D. R.; Palmieri, G.; Chase, D. L.; Longo, D. L.; Ferris, D. K.
  3. Biochemical Journal. 1999 339(Part 2): 435-442.
  1. 23.   Expression and Phosphorylation of Fibroblast-Growth-Factor-Inducible Kinase (Fnk) During Cell-Cycle Progression
  2. Chase, D.; Feng, Y.; Hanshew, B.; Winkles, J. A.; Longo, D. L.; Ferris, D. K.
  3. Biochemical Journal. 1998 333(Part 3): 655-660.
  1. 24.   Ubiquitination and Proteasome Mediated Degradation of Polo-Like Kinase
  2. Ferris, D. K.; Maloid, S. C.; Li, C. C. H.
  3. Biochemical and Biophysical Research Communications. 1998 252(2): 340-344.
  1. 25.   Synergy Between the Mos/Mitogen-Activated Protein Kinase Pathway and Loss of P53 Function in Transformation and Chromosome Instability
  2. Fukasawa, K.; Vande Woude, G. F
  3. Molecular and Cellular Biology. 1997 17(1): 506-518.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel